María Constanza Camargo

Camargo was born to Aracely and Efrain.^[1] She completed a B.Sc. in bacteriology from the Universidad Colegio Mayor de Cundinamarca [es] in 1992.^[1] She completed a M.H.A degree from the Pontifical Xavierian University in 1997.^[2] In 2002, Camargo earned an M.Sc. in epidemiology from the Instituto Nacional de Salud Pública.^[2] She was a member of the research group led by Pelayo Correa, first at Louisiana State University and then at Vanderbilt University, studying gastric cancer and its primary risk factor, Helicobacter pylori infection.^[2][1] In 2010, Camargo received a Ph.D. in public health with a concentration in epidemiology from the University of Illinois Chicago.^[2] Her dissertation was titled The role of EBV in gastric carcinogenesis epidemiologic modeling and molecular investigations.^[1] Garth Rauscher was her doctoral advisor.^[1] She conducted her dissertation work at the National Cancer Institute (NCI) infections and immunoepidemiology branch (IIB) on the role of Epstein–Barr virus infection in gastric carcinogenesis.^[2] She joined IIB as a postdoctoral fellow in 2010 and became an Earl Stadtman Tenure-Track Investigator in the metabolic epidemiology branch (MEB) in 2016.^[2][3]